The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 254, 112572
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged SwordMolecular Neurobiology, 2018
- Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological targetPharmacological Research, 2018
- Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic processBiochemical and Biophysical Research Communications, 2018
- Hyperprolactinemia, prolactin-related side effects and quality of life in Chinese psychiatric patientsComprehensive Psychiatry, 2016
- Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual DysfunctionThe Journal of Sexual Medicine, 2009
- Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cellsEuropean Journal of Pharmaceutical Sciences, 2003
- Dopamine as a Prolactin (PRL) InhibitorEndocrine Reviews, 2001
- Estrogen Receptor α Interaction with Estrogen Response Element Half-Sites from the Rat Prolactin GeneBiochemistry, 2000
- Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patientsThe American Journal of Medicine, 1981
- Loss of Central Nervous System Component of Dopaminergic Inhibition of Prolactin Secretion in Patients with Prolactin-Secreting Pituitary TumorsJournal of Clinical Investigation, 1978